Immix Biopharma (IMMX) Current Leases (2024 - 2026)
Immix Biopharma's (IMMX) quarterly Current Leases came in at $125392.0 in Q1 2026, up 84.9% year-on-year from $67817.0 in Q1 2025, and down 10.01% quarter-over-quarter from $139339.0 in Q4 2025.
Immix Biopharma (IMMX) Current Leases (2024 - 2026) Analysis & Trends
Immix Biopharma has disclosed Current Leases across 3 years of filings, most recently posting $125392.0 for Q1 2026.
- Current Leases for Q1 2026 came in at $125392.0, up 84.9% year-over-year; the trailing twelve-month figure through Mar 2026 was $125392.0 (up 84.9% YoY), and the FY2025 annual result was $139339.0, up 113.65% from the prior year.
- Current Leases came in at $125392.0 for Q1 2026 at Immix Biopharma, down from $139339.0 in the prior quarter.
- In the past five years, Current Leases ranged from a high of $141282.0 in Q3 2025 to a low of $34284.0 in Q1 2024.
- The 3-year median for Current Leases is $67817.0 (2025), against an average of $83874.9.
- Peak annual rise in Current Leases reached 125.28% in 2025, while the deepest fall reached 45.72% in 2025.
- Immix Biopharma's Current Leases stood at $65219.0 in 2024, then soared by 113.65% to $139339.0 in 2025, then dropped by 10.01% to $125392.0 in 2026.
- The last three Current Leases figures came in at $125392.0 (Q1 2026), $139339.0 (Q4 2025), and $141282.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 814,307.08 Bn | 814,307.05 Bn | - | 42,980.09 |
| 2 | Belite Bio | 55,320.00 Bn | 55,320.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,149.72 Bn | 17,149.72 Bn | - | 83,991.00 |
| 4 | Legend Biotech | 3,590.00 Bn | 3,589.71 Bn | 242.10 Mn | 7.40 Mn |
| 5 | Akari Therapeutics | 1,650.72 Bn | 1,650.72 Bn | - | - |
| 6 | Evaxion A | 1,522.09 Bn | 1,522.07 Bn | - | - |
| 7 | Psyence Biomedical | 229.39 Bn | 229.38 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 113.09 Bn | 105.85 Bn | 2.59 Bn | - |
| 9 | Abivax | 90.15 Bn | 90.15 Bn | - | - |
| 10 | Immix Biopharma | 467.59 Mn | 467.59 Mn | - | 125,392.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 125,392.00 |
| Dec 31, 2025 | 139,339.00 |
| Sep 30, 2025 | 141,282.00 |
| Jun 30, 2025 | 70,467.00 |
| Mar 31, 2025 | 67,817.00 |
| Dec 31, 2024 | 65,219.00 |
| Sep 30, 2024 | 62,715.00 |
| Jun 30, 2024 | 48,359.00 |
| Mar 31, 2024 | 34,284.00 |